Covered recipient · General Payments record
SARAH PUCHALA LUCERO
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2022–2024
$1,400.41
- Reported across 68 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $331.72 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $73.56 | 4 |
| ABBVIE INC. | $73.49 | 4 |
| PFIZER INC. | $60.53 | 4 |
| Lilly USA, LLC | $51.55 | 3 |
| Novo Nordisk AS | $41.92 | 2 |
| GlaxoSmithKline, LLC. | $30.67 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.79 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107563254 | CMS |
| ABBVIE INC. | $27.83 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107563256 | CMS |
| ABBVIE INC. | $13.26 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107563258 | CMS |
| ABBVIE INC. | $17.61 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107563260 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.03 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104621582 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.41 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105839603 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.28 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104748263 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.84 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105537209 | CMS |
| GlaxoSmithKline, LLC. | $15.15 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116198137 | CMS |
| GlaxoSmithKline, LLC. | $15.52 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116482013 | CMS |
| Lilly USA, LLC | $14.45 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135941592 | CMS |
| Lilly USA, LLC | $18.21 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135905157 | CMS |
| Lilly USA, LLC | $18.89 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135933544 | CMS |
| Novo Nordisk Inc | $18.17 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100278770 | CMS |
| Novo Nordisk Inc | $23.75 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100287886 | CMS |
| PFIZER INC. | $17.84 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131236215 | CMS |
| PFIZER INC. | $15.32 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131368916 | CMS |
| PFIZER INC. | $13.95 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131658937 | CMS |
| PFIZER INC. | $13.42 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131792457 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.